The effects of bromocryptine (CB-154) on prolactin (PRL) and luteinizing hormone (LH) secretion were studied in lactating sows and ovariectomized (OVX) gilts. In Exp. 1, the litters of four sows were standardized to four pigs each at 20 to 30 d of lactation and a cannula was placed nonsurgically into the jugular vein of each sow. Twenty-four hours later (0800 h) blood samples were taken and two sows each were injected subcutaneously with 120 mg CB-154 or vehicle. Blood samples were then taken every 30 min for the next 23.5 h. An additional six sows whose litters were standardized to six pigs each at 28 to 30 d of lactation comprised Exp. 2. In Exp. 3, five puberal gilts were OVX. Forty-eight hours after OVX a cannula was placed into the jugular vein. The day after cannulation blood samples were drawn every 30 rain from 0800 to 2400 h. Immediately after the sampling at 1200 h, two gilts were injected subcutaneously with 120 mg CB-154 and three were injected subcutaneously with vehicle. Exp. 4 was a repetition of Exp. 3 except that six gilts were OVX 10 d before the experiment and three each were treated with CB-154 or vehicle. Serum PRL concentrations 1 The authors thank Dr. Elton of Sandoz, Inc., East Hanover, NJ 07936, for providing the bromocryptine (CB-154) used in this study, and gratefully acknowledge Dr. Leo E. Reiehert, Jr., of The Albany Medical College, Albany, NY, for providing the purified pituitary hormones used in our radioimmunoassays.
Introduction
The role of brain monoamines and histamine in regulating anterior pituitary secretion has been extensively studied (see review by Weiner and Ganong, 1978) . Many studies using rodents, sheep, dogs, rabbits, monkeys and humans, as well as hamsters (Terranova and Greenwald, 1978) and cattle (Johke and Hodate, 1978; Beck et al., 1979) , are in agreement that dopamine and dopamine agonists inhibit prolactin (PRL) secretion. However, there are conflicting reports concerning the effect of dopamine and dopamine agonists on luteinizing hormone (LH) secretion. Because data are lacking in the pig, this study was conducted to determine the effect of the dopamine agonist, bromocryptine (CB-154), on PRL and LH secretion in the pig.
Materials and Methods
Two animal models were used: (1) the 1212 JOURNAL OF ANIMAL SCIENCE, Vol. 54, No. 6, 1982 lactating sow, in which the relative concentration of serum PRL is high (Threlfall et al., 1974; Bevers et al., 1978; van Landeghem and van de WieI, 1978) and the relative concentration of serum LH is low (Stevenson et al., 1978) and (2) the ovariectomized (OVX)gilt, in which serum PRL is low and LH is high (Wilfinger et al., 1974; Hoover et al., 1977) .
Lactating Sows
Exp. 1. The litters of four sows were standardized to four pigs each at 28 to 30 d of lactation and an indwelling tygon cannula was placed nonsurgicaUy into the jugular vein of each sow as follows: the sow was restrained with a snare and the cannula was passed through an 11 gauge thin-walled, 8.89-cm hypodermic needle that had been placed into the jugular vein. The cannula was secured and protected on the outside of the neck by a 7.62-cm wide elastic bandage wrapped around the neck and shoulder area. Twenty-four hours after cannulation, two sows were injected subcutaneously with 120 mg CB-154 in 70% ethanol (ETOH) and two sows were injected subcutaneously with ETOH vehicle immediately after the first blood sample was drawn at 0800 h. Samples were taken every 30 min for the next 23.5 h. The baby pigs were allowed to suckle throughout the experimental period.
Exp. 2. Exp, 1 was repeated with an additional six sows whose litters were standardized to six pigs each at 28 to 30 d of lactation. Exp. 1 was conducted in November in a farrowing house under natural photoperiod and Exp. 2 in January in a different farrowing house under artificial photoperiod conditions of 8 h light: 16 h dark.
Ovariectomized Gilts
Exp. 3. Five gilts that had displayed two or more estrous cycles of 18 to 21 d were ovariectomized (OVX) on d 7 to 9 of the estrous cycle by mid-ventral laparotomy. Forty-eight hours after OVX an indwelling cannula was placed into the jugular vein as described for the lacSBiogel, P-60, Bio Rad Laboratories, 32nd and Griffin, Richmond, CA. Mention of a trade name, proprietary product or specific equipment does not constitute a guarantee or warranty by the USDA or the Univ. of Georgia and does not imply its approval to the exclusion of other products.
6 AG1-XIO, Bio Rad Laboratories.
tating sows. The day after cannulation, blood samples were drawn from the cannula every 30 min from 0800 to 2400 h. Immediately after the sampling at 1200 h, two gilts were injected subcutaneously with 120 mg CB-154 in 70% ETOH and three gilts were injected subcutaneously with ETOH vehicle.
Exp. 4. An additional six gilts that had displayed two or more estrous cycles of 18 to 21 d were OVX on d 5 to 8 of the estrous cycle, and the experiment was repeated beginning 10 to 13 d after OVX. Exp. 3 was conducted in May and Exp. 4 in June in the same finishing unit under natural photoperiod. Blood samples were stored at 4 C for approximately 12 h and then centrifuged, and the serum was stored at -20 C until analyzed for PRL and LH by double-antibody radioimmunoassays.
Luteinizing Hormone Radioimmunoassay.
Blood serum LH was quantified by a heterologous double-antibody radioimmunoassay. The antiserum was produced in rabbits against bovine LH (NIH-LH-B9) according to the procedure of Vaitukaitis et al. (1971) . Purified porcine LH was used for iodination and standards (LER-778-4). Aliquots of 2.5 gig LH in 2.5 /al of distilled water were iodihated by the chloramine-T method (Greenwood et al., 1963) . At each iodination, 20 gtl of .5 M phosphate buffer (pH 7.5) were added to the reaction vial containing the porcine LH, and 30 gtl of .05 M phosphate buffer (pH 7.5) were added to the vial containing 1 mCi Na 12s I. The Na lzsI was added to the reaction vial and 100 gig chloramine-T (5 gtg/gtl .5 M phosphate buffer, pH 7.5) were mixed with the LH and Na l~Sl for 2 min. The reaction was stopped with 100 /~g sodium metabisulfate (5 gtg//al .5 M phosphate buffer, pH 7.5) added to the reaction mixture for 1 min. The reaction mixture was diluted with 100 /al of 1.0% potassium iodide and layered on a .8 x 20 cm gel filtration column s for separation of free I from t2SI-LH. The 12SI-LH was then purified on a .6 • 17 cm anion exchange column 6.
For the assay, 200 /~1 of .01 M phosphate buffered saline containing 1% bovine serum albumin, pH 7.5 (1% BSA-PBS); 300 gtl of serum sample or standard in 300 #I 1% BSA-PBS, and 200 /ll rabbit anti-bovine LH serum were added to the assay tubes. The anti-bovine LH serum was diluted at 1:160,000 with 1% BSA-PBS containing 1:400 normal rabbit serum. Nonspecific binding tubes contained 200 /21 of 1:400 normal rabbit serum in place of the first antibody. All tubes were incubated for 24 h at 4 C. One hundred microliters of 1% BSA-PBS containing 12SI-LH (10,000 cpm) were added to each tube and incubated for 24 h at 4 C. Then, 200/21 of sheep anti-rabbit serum, diluted at 1:30 in 1% BSA-PBS, were added to the assay tubes and incubated for 48 h at 4 C. After 48 h, 3 ml of cold PBS were added to each tube and centrifuged at 1,500 g for 30 min to separate antibody bound 12SI-LH from the free 12SI-LH. The supernatant was decanted and the radioactivity in the remaining pellet was counted in a scintillation counter 7. The dilution of first antibody bound 20 to 30% of the 12SI-LH. Standard curves consisted of tubes containing .1, .2, .4, .6, .8, 1.0, 1.5, 2.0, 5.0 or 10 ng LH.
Dose response curves for pooled porcine serum and increasing concentrations of the LH standard added to a porcine serum pool were parallel (P>.5) to the standard curve. LH (ranging from .4 to 5 ng) added to porcine serum was consistently recovered from 300 gtl of serum (I00 + 4%). Cross-reactions of the antibody with large quantities of other preparations of pituitary hormones (.1 to 1,000 ng) were: follicle stimulating hormone (NIH-FSH-P-2), 2.4%; growth hormone (NIH-GH-P-526B), 2.0% and PRL (LER-2073), <.001%. Sensitivity of the assay was .1 ng LH/tube. Intraassay and interassay coefficients of variation were 8.4 and 10.5%, respectively.
Prolactin Radioimmunoassay. Blood serum PRL was quantified by a homologous doubleantibody radioimmuno-assay. The antiserum, produced in goats, was purchased from Research Products, International Corporation s . Purified porcine PRL (LER-2073) was used for iodination and standards. Aliquots of 5/ag PRL in 5 gtl of distilled water were iodinated by the chloramine-T method (Greenwood et al., 1963) . At each iodination, 25 gtl of .5 M phosphate buffer (pH 7.5) were added to the reaction vial containing the porcine PRL and 20 gtl of .05 M phosphate buffer (pH 7.5) were added to the vial containing 1 mCi Na 12Sl. One-half of the Na 12si was added to the reaction vial 7Model 1285, Tracor, Tracor Analytic, Inc., 1842 Brummel Drive, Elk Grove Village, IL 60007.
6Research Products International Corp., 2692 Delta Lane, Elk Grove Village, IL 60007. and 20 gtg chloramine-T (1.0 gtg/gtl of .5 M phosphate buffer, pH 7.5) were mixed with the PRL and Na 12si for 20 s. The reaction was stopped with 50 gig sodium metabisulfate (1.0 gg/ml of .5 M phosphate buffer, pH 7.5) added to the reaction mixture for 30 s. The reaction mixture was diluted with 100 gtl of 1.0% potassium iodide and was layered on a .85 x 17.5 cm gel filtration column s to separate free 1251 from 12SI-PRL. The 12SI-PRL was then purified on a .6 • 17 cm anion exchange column 6 .
For the assay, 200 /al of 1% BSA-PBS, 100 /al of serum sample or standard in 100 ~1 of 1% BSA-PBS, 100 ~tl goat antiporcine PRL serum diluted at 1:50,000 in 1% BSA-PBS containing 1:200 normal goat serum and 100 /al of 1% BSA-PBS containing 12SI-PRL (10,000 cpm) were added to each tube. Nonspecific binding tubes contained 100 /.tl of 1:200 normal goat serum in place of the first antibody. All tubes were incubated for 24 h at 4 C. Then, 200 /.tl of rabbit anti-goat gamma globulin serum diluted at 1:15 in 1% BSA-PBS were added to the assay tubes and incubated for 12 h at 4 C. Three milliliters of cold PBS were added to each tube and centrifuged at 1,500 g for 30 rain to separate bound 12SI-PRL from free 12sI-PRL. The supernatant was decanted and the radioactivity in the remaining pellet counted. The dilution of first antibody bound 20 to 30% of the 12SI-PRL. Tubes for standard curves con contained .2, .3, .6, 1.0, 2.0, 3.0, 6.0, 10.0, 15.0 or 20 ng PRL. Dose response curves for pooled porcine serum and for increasing concentrations of the standard PRL added to a porcine serum pool were parallel (P>. 3) to the standard curve. PRL (ranging from .1 to 16 ng) added to the porcine serum was consistently recovered from 100/al of serum (99.2 + .4%). Cross-reactions of the antibody with large quantities (2 to 2,000 ng) of FSH (NIH-FSH-P-2), LH (LER-778-4) and GH (NIH-GH-P-526B) were less than 1%. Sensitivity of the assay was .2 ng PRL/tube. Intraassay and interassay coefficients of variation were 16.3 and 15.2%, respectively.
Statistical Analysis. The data before and after treatment were analyzed separately. The pretreatment data of Exp. 1 and 2 were subjected to a t test (Steel and Torrie, 1960) , whereas the post-treatment data in Exp. 1 and 2 and the pre-and post-treatment data in Exp. 3 and 4 were subjected to analysis of variance by the General Linear Models procedure of the Statistical Analysis System (Barr et al., 1976) . A split-plot in time model was used in which time was a continuous variable and treatment was a discrete variable. Predicted values (Y) were calculated using polynomial regression from the above procedures and were used to discuss the data. Specific contrasts between means were made using the upper and lower 95% confidence limits of the predicted means.
Results
Lactating Sows. Mean serum PRL concentrations in lactating sows for the 24 h experimental period after CB-154 or vehicle treatment are illustrated in figure 1 . A treatment • experiment interaction (P<.O001) was detected for the post-treatment data. Consistently greater serum PRL concentrations in the control sows of Exp. 2 than in the control sows of Exp. 1 probably accounted for this interaction. Serum PRL concentrations were similar in the first blood sample at 0800 h for the control sows and the sows treated with CB-154 in both Exp. 1 and 2, whereas serum PRL concentrations were lower (P<.05) in sows treated with CB-154 than in control sows throughout the -~ 2000  2400  0400  0800   Treatment  Exp 2   I  I  I  I  I  I  I  I  I  I  I  I  ~  I  I  I  I  I  I  I  I  I  I  I  I   0800  1200  1600  2000  2400  0400  0800 HOURS Figure 1 . Serum prolactin concentrations in lactating sows for the 24-h period after administration of CB-154 (n = 2 for Exp. I and n = 3 for Exp. 2) or vehicle (n --2 for Exp. 1 and n = 3 for Exp. 2).
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remainder of the sampling period in both experiments. In Exp. 1, serum PRL of control sows decreased from 31 ng/ml at 0800 h to 13 ng/ml at 1630 h and remained stable until 2430 h, after which it increased for 7.5 h to 17-24 ng/ml. In Exp. 2, there was an increase in serum PRL in control sows from 39 ng/ml at 0800 h to a maximal concentration of 93 ng/ml at 1230 h. Serum PRL then decreased to 31 ng/ml over the next 7.5 h, and by the end of the bleeding period, increased again to 39 ng/ml. In contrast, serum PRL concentrations in sows treated with CB-154 decreased (P<.05) from 35 ng/ml at 0800 h to 5 ng/ml at 1630 h in Exp. 1 and from 45 ng/ml at 0800 h to 7 ng/ml at 2300 h in Exp. 2 and then stabilized at these approximate concentrations for the remainder of the experimental period. These patterns of PRL concentrations resulted in a time x treatment interaction (P<.O001) in Exp. 2 but not in Exp. 1.
Mean serum LH concentrations in lactating sows for the 24 h experimental period after CB-154 or vehicle treatment are shown in figure 2. A treatment x experiment interaction (P<.01) was detected for the post-treatment data. In Exp. 1, average serum LH concentrations ranged from 1.7 to 10.0 ng/ml in control sows over the 24 h sampling period, and from 1.3 to 4.6 ng/ml in sows treated with CB-154. Serum I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I   0 800  1200  1600  2000  2400  0400  0800 HOURS Figure 2 . Serum luteinizing hormone concentrations in lactating sows for the 24-h period after treatment with CB-154 (n = 2 for Exp. 1 and n = 3 for Exp. 2) or vehicle (n = 2 for Exp. 1 and n = 3 for Exp. 2).
LH concentrations were similar for all sows from 0800 to 1350 h and from 2250 h to the end of the sampling period. However, between 1350 and 2250 h, serum LH was lower (P<.05) in the sows treated with CB-154 than in the control sows.
Average serum LH concentrations over the 24 h sampling period in Exp. 2 ranged from 1.0 to 3.0 ng/ml for the control sows and from .3 to 1.7 ng/ml for the sows treated with CB-154. Serum LH concentrations were lower (P<.05) in the sows treated with CB-154 than in the control sows throughout the sampling period in Exp. 2.
Ovariectomized Gilts. Serum PRL concentrations in OVX gilts treated with CB-154 or vehicle are shown in figure 3 . A treatment x experiment interaction was detected for both the pretreatment (P<.05) and post-treatment (P<.0001) sampling periods. Serum PRL concentrations in OVX gilts of Exp. 3 appeared to be generally threefold greater than those of Exp. 4. In Exp. 3, average serum PRL concentration ranged from 17 to 25 ng/ml for OVX control gilts and from 14 to 20 ng/ml for OVX gilts treated with CB-154. Serum PRL concentrations were similar for both groups during the first 5.5 h of the sampling period. During the remainder of the sampling period serum PRL concentrations were lower (P<.05) in OVX gilts treated with CB-154 than in OVX control gilts. A time x treatment interaction was detected (P<.05).
In Exp. 4, average serum PRL concentration ranged from 5 to 12 ng/ml for OVX control gilts and from 2 to 24 ng/ml for OVX gilts treated with CB-154. Serum PRL concentrations were similar for both groups over the first 6.5 h, but were lower (P<.05) in OVX gilts treated with CB-154 than in OVX control gilts for the remainder of the sampling period. These patterns of serum PRL concentrations resulted in a time x treatment interaction (P<.0001).
Serum LH concentrations for OVX gilts treated with CB-154 or vehicle are illustrated in figure 4 . Treatment x experiment interactions (P<.0001) were detected for the pretreatment and post-treatment periods. In Exp. 3, average serum LH concentration ranged from 1.6 to 3.5 ng/ml for the OVX control gilts and from 1.0 to 2.4 ng/ml for the OVX gilts treated with CB-154. Serum LH concentrations were not different in OVX gilts treated with CB-154 and OVX control gilts from 0800 to 1630 h. For the remainder of the sampling period serum LH concentrations of OVX gilts treated with CB-154 were lower (P<.05) than those of the OVX controls. In Exp. 4, average serum LH concentrations ranged from 1.5 to 4.0 ng/ml for OVX control gilts and from 2.3 to 4.5 ng/ml for OVX gilts treated with CB-154. Serum LH concentrations were similar for both groups throughout the sampling period. The time • treatment interaction was significant (P<.05) in Exp, 2, but not in Exp. 1.
Discussion
Lactating Sows. In both Exp. 1 and 2, baseline serum PRL concentrations were threeto fourfold lower in sows treated with CB-154 than in control sows by 1800 h, indicating that CB-154 was a potent depressor of PRL secretion in the lactating sow. The transient rise and fall of serum PRL concentrations in the control sows of both experiments during the first 8 to 10 h of the blood sampling period may reflect either a diurnal variation or a response to feeding. The sows treated with CB-154 failed to display this transient rise and fall in serum PRL concentrations. Litter size was adjusted to four pigs in Exp. 1 and to six pigs in Exp. 2. Perhaps differences in suckling intensity accounted for the significant treatment • experiment interaction. Data reported by Mulloy and Malven (1979) indicates that increasing litter size may increase the suckling-induced release of PRL in pigs. Other factors that might influence serum PRL concentrations in pigs are photoperiod and temperature. Alteration of blood PRL concentrations by photoperiod has been demonstrated in the sheep by Sanford et al. (1978) , Thimonier et al. (1978) and Walton et al. (1980) and in cattle by Peters and Tucker (1978) and Leining et al. (1979) . Alteration of blood PRL concentrations by temperature has been demon- strated in cattle by Tucker and Wettemann (1976) and Peters and Tucker (1978) .
Serum LH concentrations of control sows in Exp. 1 were higher than those reported by Stevenson et al. (1978) , whereas serum LH concentrations of control sows in Exp. 2 were similar to those reported by Stevenson et al. (1978) . Serum LH concentrations in both the control sows and the sows treated with CB-154 appeared to be higher in Exp. 1 than in Exp. 2, which could be due to the greater suckling intensity from six pigs/litter in Exp. 2 than from four pigs/litterin Exp. 1. Stevenson et al. (1978) have shown that suckling suppressed LH release in lactating sows. Because CB-154 treatment was associated with significandy lower serum LH concentrations than that of control sows we concluded that CB-154 suppressed LH secretion in the lactating sow. Dopamine and doparnine agonists also suppressed LH secretion in intact humans, OVX rats and OVX sheep (Weiner and Ganong, 1978; Hill et al., 1980; Owens et al., 1980) . Ovariectomized Gilts. Because serum PRL concentrations decreased after injection of CB-154 in both Exp. 3 and 4, resulting in a significant (P<.05) difference in serum PRL between the OVX control gilts and the OVX gilts treated with CB-154, these data further demonstrate that CB-154 was a potent depressor of PRL secretion in the pig. The influence of CB-154 on PRL secretion in the OVX gilts was not as dramatic as that observed in the lactating sows. Perhaps serum PRL concentrations were already at basal levels in the OVX gilts because of the absence of a stimulus for PRL release such as suckling.
In both Exp. 3 and 4, serum LH concentrations were similar for all animals before CB-154 injection. In Exp. 3, serum LH concentrations in OVX gilts treated with CB-154 were lower (P<.05) than those of control OVX gilts in the latter part of the sampling period, while in Exp. 4, serum LH concentrations were similar for all animals throughout the sampling period. Therefor, unlike the lactating sow, the OVX sheep (Hill et al., 1980) and OVX rat (Owens et al., 1980) it is not possible to conclude whether or not CB-154 inhibited LH secretion in the OVX gilts. Weiner and Ganong (1978) have concluded that reports in the literature concerning the effect of dopamine and dopamine agonists on LH secretion are conflicting because multiple dopaminergic pathways are involved in the control of both the tonic and(or) phasic release of LH. In addition, the central regulation of LH may be complex and involve a multiplicity of neural connections and, therefore, drug studies may be misleading due to actions at multiple sites with opposite effects.
Results indicate that changes in serum PRL concentrations were greater in the lactating sows than in the OVX gilts, whereas changes in serum LH concentrations were similar in animals in these two physiological states. Serum PRL was consistently depressed after CB-154 treatment in both the lactating sows and the OVX gilts, but changes in serum LH concentrations after CB-154 treatment were not consistent among the four groups. Therefore, we conclude that CB-154 depressed PRL secretion in the lactating sows and OVX gilts. In addition, CB-154 depressed LH secretion in the lactating sows, but the data are inconclusive as to whether CB-154 influenced LH secretion in the OVX gilts.
